Medizinische Universität Graz - Research portal
Selected Publication:
SHR Neuro Cancer Cardio Lipid Metab Microb
Rudzinski, PN; Leipsic, JA; Schoepf, UJ; Dudek, D; Schwarz, F; Andreas, M; Zlahoda-Huzior, A; Thilo, C; Renker, M; Burt, JR; Emrich, T; Varga-Szemes, A; Amoroso, NS; Steinberg, DH; Pukacki, P; Demkow, M; Kepka, C; Bayer, RR.
CT in Transcatheter-delivered Treatment of Valvular Heart Disease
RADIOLOGY. 2022; 304(1): 4-17.
Doi: 10.1148/radiol.210567
Web of Science
PubMed
FullText
FullText_MUG
- Co-authors Med Uni Graz
- Andreas Martin
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Minimally invasive strategies to treat valvular heart disease have emerged over the past 2 decades. The use of transcatheter aortic valve replacement in the treatment of severe aortic stenosis, for example, has recently expanded from high- to low-risk patients and became an alternative treatment for those with prohibitive surgical risk. With the increase in transcatheter strategies, multimodality imaging, including echocardiography, CT, fluoroscopy, and cardiac MRI, are used. Strategies for preprocedural imaging strategies vary depending on the targeted valve. Herein, an overview of preprocedural imaging strategies and their postprocessing approaches is provided, with a focus on CT. Transcatheter aortic valve replacement is reviewed, as well as less established minimally invasive treatments of the mitral and tricuspid valves. In addition, device-specific details and the goals of CT imaging are discussed. Future imaging developments, such as peri-procedural fusion imaging, machine learning for image processing, and mixed reality applications, are presented. (C) RSNA, 2022